The Analysis of Plasma Proteomics for Luminal A Breast Cancer
The study revealed proteomic signatures of patients with luminal A breast cancer, identified multiple differential proteins, and identified three plasma proteins as potential diagnostic biomarkers for breast cancer. It provides a reference for the screening of biomarkers for breast cancer.
Authors
- Yongtong Cao (ORCID: https://orcid.org/0000-0002-2019-7088)
- Guo‐Xiong Deng (ORCID: https://orcid.org/0000-0001-9199-8504)
- Haoyan Zhu (ORCID: https://orcid.org/0009-0005-8535-1620)
- Yongwei Jiang (ORCID: https://orcid.org/0000-0002-4974-0283)
- Ziyi Feng (ORCID: https://orcid.org/0000-0001-6113-5097)
- Meimei Zhao (ORCID: https://orcid.org/0000-0002-6031-5544)
- Liang Ma (ORCID: https://orcid.org/0000-0003-3226-4150)
- Xiaomu Kong (ORCID: https://orcid.org/0000-0002-5920-4759)
- Peng Gao (ORCID: https://orcid.org/0000-0002-7096-2710)
- Mo Li (ORCID: https://orcid.org/0000-0002-6047-9709)
- Yi Liu (ORCID: https://orcid.org/0000-0002-6733-9389)
Institutions
- China-Japan Friendship Hospital (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/cam4.70470
- Citations
- 4
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.14
Funders
- National Natural Science Foundation of China
- China-Japan Friendship Hospital